Jolt #3: Healthcare Caffeine, WoundSource Edition
by Colton Mason
Salt Lake City, August 22, 2019 – PolarityTE®, Inc., a biotechnology company developing and commercializing regenerative tissue products and biomaterials, presented data on the potential for SkinTE™ and OsteoTE™ to address military-related traumas and chronic wounds at the Military Health System Research Symposium on August 21, 2019, in Kissimmee, FL.
SkinTE is a first-of-its-kind autologous, homologous human cellular and tissue-based product designed to regenerate full-thickness, functional skin for the repair, reconstruction and replacement of a patient's own skin. OsteoTE, based on the same platform technology, is an autologous, homologous human cellular and tissue-based product intended to repair, reconstruct, replace and supplement bone.
"PolarityTE is committed to advancing research and developing potential new treatment options for our armed forces and veterans to help them recover from traumatic and chronic wounds and burns," said Nikolai Sopko, MD, PhD, Chief Scientific Officer, PolarityTE. "We will continue to pursue opportunities and synergies with the defense community in hopes that we will make a true impact on treatment options for these patients and providers."
PolarityTE also recently announced that it has been granted a patent in Canada related to its unique micro-aggregate technology capable of assembling functional polarized tissue, as well as methods for producing compositions including these micro-aggregates, and the use of these micro-aggregates for therapeutic treatment of skin, skin repair and skin restoration.
PolarityTE is focused on transforming the lives of patients by discovering, designing and developing a range of regenerative tissue products and biomaterials for the fields of medicine, biomedical engineering and material sciences. Rather than manufacturing with synthetic and foreign materials within artificially engineered environments, PolarityTE manufactures products from the patient's own tissue and uses the patient's own body to support the regenerative process. From a small piece of healthy autologous tissue, the company creates an easily deployable, dynamic and self-propagating product designed to regenerate the target tissues. PolarityTE's innovative method is intended to promote and accelerate growth of the patient's tissues to undergo a form of effective regenerative healing. Learn more at www.PolarityTE.com – Welcome to the Shift®.
The views and opinions expressed in this blog are solely those of the author, and do not represent the views of WoundSource, Kestrel Health Information, Inc., its affiliates, or subsidiary companies.